Likewise, the aberrant elevation of Runt-related transcription factor 2 (RUNX2) positively correlated with anti-cancer resistance in various cancers, such as osteosarcomas, breast cancer, and pancreatic cancer108–110. Here, RUNX2 is linked to breast cancer.